Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02920268
Other study ID # 209695
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 2016
Est. completion date December 2023

Study information

Verified date October 2022
Source Region Örebro County
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recurrent abdominal pain affects up to 37% of school-age children, mostly girls. These problems results in decreased quality-of-life, absence from school, lower sleep quality and increased health-care consumption. Long-term effects are lasting pain-symptoms and increased risk for psychiatric illness. The scientific evidence for interventions towards long-term pain in children is limited and pharmacological treatment is not effective. Cognitive behavioral therapy has shown some effect but is time- and resource consuming. Dance and yoga can enhance positive protective factors through better body awareness and increased self-regulation. Relaxation in yoga also has positive effect on abdominal pain. The aim of this study is to evaluate the effects of an intervention with dance and yoga for girls, 9 to 13 years old, with recurrent abdominal pain. The participants will be identified through pediatric clinics in Örebro County, primary health care and school health care. They will be randomized to intervention with weekly dance- and yoga class for 8 months or control group with standard treatment. Primary outcome is the fraction of girls in each group who, direct after intervention, has decreased their maximum pain measured by Faces Pain Scale. Secondary outcomes are stress, psychical health, well-being, school and sleep functions, physical activity and health-economy. The study group will be followed up for two years. Just-in-TIME is an interdisciplinary research group with expertise in interventions for psychosomatic problems in children and adolescents. TIME, which stands for Try, Identify, Move and Enjoy, also characterizes this project, aiming at decreasing recurrent abdominal pain through an intervention with dance and yoga for 9-13 year old girls.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 121
Est. completion date December 2023
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender Female
Age group 9 Years to 13 Years
Eligibility Inclusion Criteria: Girls 9-13 years old as of pediatricians receive or have received the diagnosis functional abdominal pain or IBS according to the ROME III criteria and stating that they have persist symptoms for at least 2 months after completed investigation from pediatricians. Persistent symptoms are measured by pain diary at baseline and means that the girl at least once in the pain diary estimates 4 or higher as measured by the Faces Pain Scale (FPS-R). Exclusion Criteria: - Simultaneous celiac disease or inflammatory bowel disease (IBD). - Difficulties in following verbal instructions such as hearing impaired or mentally retarded. - Girls who are deemed to have such serious psychological symptoms that other treatment is required. All participants in the study, which estimates over 13 at the Children's Depression Screener (Child-S), will meet a psychologist / psychiatrist to assess whether they can participate in the study or have direct access to the Children and Youth psychiatry. - Children treated with CBT.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dance and yoga intervention


Locations

Country Name City State
Sweden University health care research center, Region Örebro county Örebro

Sponsors (2)

Lead Sponsor Collaborator
Region Örebro County Örebro University, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Faces pain scale (FPS-R) Has the perceived abdominal pain decreased by a 8 months long intervention with regular dance and yoga for girls with recurrent abdominal pain, measured immediately after the intervention compared to the control group? The primary outcome is the proportion of girls in each group that have lowered their maximal abdominal pain measured by Faces Pain Scale (FPS-R). 24 months
See also
  Status Clinical Trial Phase
Completed NCT04677881 - Health Effects of Different Types of Bread N/A
Completed NCT02293343 - 24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance N/A
Completed NCT01717404 - Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C) Phase 1
Withdrawn NCT02313207 - Confocal Laser Endomicroscopy in IBS Patients N/A
Completed NCT02937506 - Patient Satisfaction With Propofol for Out Patient Colonoscopy Phase 4
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Completed NCT02419963 - Analyzing IBS to Identify Biomarkers and Microbiome Signatures N/A
Not yet recruiting NCT06389851 - Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD N/A
Recruiting NCT05815602 - Ebastine Versus Mebeverine in IBS Patients Phase 3
Completed NCT03482765 - A Study of Probiotics in IBS Subjects N/A
Completed NCT03986476 - The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome N/A
Not yet recruiting NCT05737277 - Gabapral in Pediatric IBS N/A
Active, not recruiting NCT05718505 - Comparison of the Atmo Motility Gas Capsule System to the Reference Standard N/A
Recruiting NCT06072287 - The Living With a Long-Term Condition Study
Completed NCT04953728 - Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C N/A
Completed NCT02681666 - Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome N/A
Completed NCT02981888 - Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
Completed NCT01667627 - Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea Phase 4
Recruiting NCT01779765 - The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS) Phase 4
Completed NCT02009618 - The Effects of Rifaximin Therapy in Irritable Bowel Syndrome N/A